Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dipeptidyl-Peptidase 4 Inhibitors”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01333592
What this trial is testing

Long-term Study of KAD-1229 in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Kissei Pharmaceutical Co., Ltd. 136
Not applicableStudy completedNCT01767389
What this trial is testing

Glucagon-like Peptide (GLP) Utilization and Safety

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 1
Post-approval studies (Phase 4)Study completedNCT02406443
What this trial is testing

The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium Excretion

Who this might be right for
Type 2 Diabetes
University Health Network, Toronto 36
Large-scale testing (Phase 3)Study completedNCT06021119
What this trial is testing

Feasibility of DPP-4 Inhibitor Therapy on Advanced Hybrid Closed Loop System

Who this might be right for
Time in Range
Ain Shams University 50
Post-approval studies (Phase 4)Study completedNCT02188186
What this trial is testing

Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes
Seoul National University Bundang Hospital 200
Post-approval studies (Phase 4)Study completedNCT02024477
What this trial is testing

Effect of Saxagliptin on EPCs as a Cellular Biomarker for Evaluating Endothelial Dysfunction in Early T2DM Patients

Who this might be right for
Type 2 Diabetes
George Washington University 42
Post-approval studies (Phase 4)UnknownNCT01660386
What this trial is testing

Study of Comparing the Different Effect of DPP-4 Inhibitors and Sulfonylurea by Using "Biphase-Hyperglycemic Clamp"

Who this might be right for
Type 2 Diabetes
Shanghai Jiao Tong University School of Medicine 12
Large-scale testing (Phase 3)Study completedNCT01805830
What this trial is testing

Teneligliptin(MP-513) vs. Placebo in Patient With Metformin Monotherapy

Who this might be right for
Type 2 Diabetes
Handok Inc. 189
Not applicableStudy completedNCT00881543
What this trial is testing

"Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"

Who this might be right for
Diabetes Type 2
University of Sao Paulo General Hospital 45
Large-scale testing (Phase 3)Study completedNCT06348706
What this trial is testing

Effect of Dipeptidyl Peptidase- 4 Inhibitors on Non-Alcoholic Steatohepatitis and Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1NASH
Ain Shams University 60
Post-approval studies (Phase 4)Study completedNCT03819127
What this trial is testing

Vildagliptin in Older Adults With Diabetes and Mild Cognitive Impairment

Who this might be right for
Mild Cognitive Impairment
University of Catania 60
Post-approval studies (Phase 4)Study completedNCT02061969
What this trial is testing

ADA Linagliptin in Long Term Care

Who this might be right for
Diabetes
Emory University 140
Post-approval studies (Phase 4)Study completedNCT03267576
What this trial is testing

An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 64
Not applicableUnknownNCT03636763
What this trial is testing

Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?

Who this might be right for
Bullous Pemphigoid
Assistance Publique Hopitaux De Marseille 183
Post-approval studies (Phase 4)Study completedNCT02180334
What this trial is testing

The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones

Who this might be right for
Diabetes Mellitus, Type 2
Seoul National University Hospital 12
Not applicableStudy completedNCT04192292
What this trial is testing

Study of Sulphonylurea Synergy With DPP4 Inhibitors

Who this might be right for
Type 2 Diabetes
University of Dundee 30
Post-approval studies (Phase 4)Study completedNCT02089438
What this trial is testing

DPP-4 Inhibition, Incretins and Islet Function

Who this might be right for
Type 2 Diabetes
Lund University 24
Testing effectiveness (Phase 2)Study completedNCT04124484
What this trial is testing

DBPR108 Tablets in Type 2 Diabetes Mellitus Patients

Who this might be right for
Type 2 Diabetes Mellitus
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 276
Large-scale testing (Phase 3)Ended earlyNCT00850239
What this trial is testing

Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Phenomix 700
Large-scale testing (Phase 3)Study completedNCT00698932
What this trial is testing

Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control

Who this might be right for
Type 2 Diabetes
AstraZeneca 568
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation